Table 2.
Details of patients in the study on mRNA expression of cytokines in psoriasis
| Age (years) | Sex | Duration (years) | PASI | PPK | Nail Disease | Type |
|---|---|---|---|---|---|---|
| 24 | M | 2.5 | 5.1 | - | - | PV |
| 58 | M | 1.5 | 9.0 | + | - | PV |
| 42 | M | 14 | 18.6 | + | - | PV |
| 38 | M | 4 | 14.0 | - | + | PV |
| 44 | M | 18 | 13.6 | + | - | PV |
| 39 | M | 4 | 7.2 | - | + | PV |
| 37 | M | 20 | 22.2 | - | + | PV |
| 33 | M | 0.5 | 23.5 | - | + | PV |
| 26 | F | 5 | 15.8 | - | + | PV |
| 36 | F | 5 | 9.1 | - | - | PV |
| 52 | F | 2 | 14.5 | - | - | PV |
| 40 | F | 5 | 12.7 | + | + | PV |
| 40 | F | 7 | 9.0 | - | + | PV |
| 50 | F | 1 | 4.6 | - | - | PV |
| 32 | F | 1 | 5.4 | - | - | PV |
PASI: Psoriasis Area Severity Index, PPK: Palmoplantar Keratoderma, PV: Psoriasis vulgaris